| Health Care Providers & Services Industry | Healthcare Sector | Mr. Jianliang Song CEO | HKEX Exchange | KYG7356A1215 ISIN |
| China Country | 321 Employees | - Last Dividend | 19 Mar 2024 Last Split | - IPO Date |
Raily Aesthetic Medicine International Holdings Limited is a prominent investment holding company specializing in aesthetic medical services. Founded in 2008 with its headquarters in Hangzhou, the People's Republic of China, the company has established a strong presence in the aesthetic medical industry. It operates through three primary segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Raily Aesthetic Medicine owns and manages a network of four private for-profit aesthetic medical institutions located in Zhejiang and Anhui Province, showcasing its significant footprint within China's aesthetic healthcare sector. As a subsidiary of Ruide Consultation Limited, the company continues to expand its reach by catering to both individual retail clients and other aesthetic medical institutions, strengthening its market position in the aesthetic medicine landscape.
Raily Aesthetic Medicine International Holdings Limited offers a comprehensive range of aesthetic medical services and products, tailored to meet the diverse needs of its clientele. These include: